Teriparatide efficacy in the treatment of severe hypocalcemia after kidney transplantation in parathyroidectomized patients: A series of five case reports

Transplantation

Volumn 92, Issue 3, 2011, Pages 316-320

  Nogueira, Estela L ^a   Costa, Ana C ^a   Santana, Alice ^a   Guerra, José O ^a   Silva, Sónia ^a   Mil Homens, Clara ^a   Costa, António G ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Hypocalcemia; Kidney transplantation; Parathyroidectomy; Teriparatide.

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CREATININE; GLUCONATE CALCIUM; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PHOSPHATE; STEROID; THYMOCYTE ANTIBODY; VITAMIN D;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ADULT; AORTA VALVE REGURGITATION; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SURGERY; HEMODIALYSIS PATIENT; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; INTESTINE OBSTRUCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUNG EDEMA; LYMPHOCELE; MALE; MITRAL VALVE REGURGITATION; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PATIENT COMPLIANCE; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SUPPLEMENTATION; TREATMENT DURATION;

ADULT; BONE DENSITY CONSERVATION AGENTS; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPOCALCEMIA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PARATHYROIDECTOMY; SEVERITY OF ILLNESS INDEX; TERIPARATIDE; TREATMENT OUTCOME;

EID: 79961022739     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182247b98     Document Type: Article

References (17)

1. Brasier AR, Nussbaum SR. Hungry bone syndrome: Clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med 1988; 84: 654.
2. Jofré R, Ló pez Gómez JM, Menárguez J, et al. Parathyroidectomy: Whom and when? Kidney Int Suppl 2003; 63: S97.
3. Evenepoel P, Van Den Bergh B, Naesens M, et al. Calcium metabolism in the early posttransplantation period. Clin J Am Soc Nephrol 2009; 4: 665.
4. Brixen KT, Christensen PM, Ejersted C, et al. Teriparatide (biosynthetic human parathyroid hormone 1-34): A new paradigm in the treatment of osteoporosis. Basic Clin Pharmacol Toxicol 2004; 94: 260.
5. Winer KK, Ko CW, Reynolds JC, et al. Long-term treatment of hypoparathyroidism: A randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab 2003; 88: 4214.
6. Winer KK, Yanovski JA, Sarani B, et al. A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. J Clin Endocrinol Metab 1998; 83: 3480.
7. Angelopoulos NG, Goula A, Tolis G. Sporadic hypoparathyroidism treated with teriparatide: A case report and literature review. Exp Clin Endocrinol Diabetes 2007; 115: 50.
8. Shiohara M, Shiozawa R, Kurata K, et al. Effect of parathyroid hormone administration in a patient with severe hypoparathyroidism caused by gain-of-function mutation of calcium sensing receptor. Endocr J 2006; 53: 797.
9. Mahajan A, Narayanan M, Jaffers G, et al. Hypoparathyroidism associated with severe mineral bone disease postrenal transplantation, treated successfully with recombinant PTH. Hemodial Int 2009; 13: 547.
10. Elming H, Holm E, Jun L, et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 1998; 19: 1391.
11. Näppi SE, Virtanen VK, Saha HH, et al. QTc dispersion increases during hemodialysis with low-calcium dialysate. Kidney Int 2000; 57: 2117.
12. Iwazu Y, Muto S, Ikeuchi S, et al. Reversible hypocalcemic heart failure with T wave alternans and increased QTc dispersion in a patient with chronic renal failure after parathyroidectomy. Clin Nephrol 2006; 65: 65.
13. Kazmi AS, Wall BM. Reversible congestive heart failure related to profound hypocalcemia secondary to hypoparathyroidism. Am J Med Sci 2007; 333: 226.
14. Saag KG, Shane E, Boonen S, et al. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 2007; 357: 2028.
15. Devogelaer JP, Adler RA, Recknor C, et al. Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis. J Rheumatol 2010; 37: 141.
16. Cejka D, Benesch T, Krestan C, et al. Effect of teriparatide on early bone loss after kidney transplantation. Am J Transplant 2008; 8: 1864.
17. Subbiah V, Madsen VS, Raymond AK, et al. Of mice and men: Divergent risks of teriparatide-induced osteosarcoma. Osteoporos Int 2010; 21: 1041.